International law firm Freshfields Bruckhaus Deringer has advised the sole underwriter, HSBC, on the rights issue by The United Laboratories International Holdings Limited, a pharmaceutical company listed on the Hong Kong Stock Exchange.
United Laboratories has raised HK$719.1 million (US$92.4million) in the rights issue. The proceeds will be used by United Laboratories to fund the expansion of its production capacity of 6-APA, being one of the intermediary products manufactured by United Laboratories and its subsidiaries, and its production plant in Inner Mongolia.
The Freshfields global capital markets team was led by Hong Kong-based partners Calvin Lai and Grace Huang. The deal team included US senior associate Iris Leung and Hong Kong associates Nicole Lew and Roland Yau.
Related Posts:
- None Found